Clinical Trials Logo

Osteoarthritis, Hip clinical trials

View clinical trials related to Osteoarthritis, Hip.

Filter by:

NCT ID: NCT06249958 Recruiting - Clinical trials for Osteoarthritis, Knee

Transforming Rehabilitation: Personalised Care for a Better Quality of Life

PREPARE
Start date: January 8, 2024
Phase:
Study type: Observational

General aim of the project: building and validating an Artificial Intelligence (AI)-based prediction model on rehabilitation outcomes (total joint replacement - TJR - of the hip and knee for primary and secondary osteoarthritis) Purpose of this specific approval request: identifying data from patients admitted for total joint replacement surgery (hip and knee) at Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Galeazzi (IOG) in 2019 and subsequently discharged to inpatient rehabilitation in the same institution.

NCT ID: NCT06233604 Recruiting - Hip Osteoarthritis Clinical Trials

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

Start date: April 10, 2024
Phase: Phase 4
Study type: Interventional

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for hip arthroplasty

NCT ID: NCT06221709 Recruiting - Hip Osteoarthritis Clinical Trials

Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This will be a prospective, single-center, double-blinded, randomized study designed to compare the efficacy of the intraarticular injection of a corticosteroid and the Conventional Radiofrequency (CRF) of the anterior sensory branches to the hip in controlling pain and improving function related to hip osteoarthritis.

NCT ID: NCT06211465 Completed - Clinical trials for Cardiovascular Diseases

Cardiovascular And Metabolic Risk After Arthroplasty

CAMERA
Start date: March 1, 2014
Phase:
Study type: Observational

Osteoarthritis is a chronic joint disease that lacks curative therapy. Epidemiological studies show increase in the burden of disease. Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. However, the specific effects of total joint arthroplasty on cardiovascular risk and metabolic profile are largely unknown. The aim of this project is to elucidate how hip and knee total joint arthroplasty impacts cardiovascular risk and metabolomic profile in comparison with general population. We hypothesize that arthroplasty decreases pain, systemic inflammation levels and increases functional status that all lead to decreased metabolic and cardiovascular risk.

NCT ID: NCT06209255 Completed - Hip Osteoarthritis Clinical Trials

Pelvic Osteotomy Of The Total Hip Replacement

Start date: August 11, 2020
Phase:
Study type: Observational

This observational study aims to learn about the outcomes in the previously operated patient and whether pelvic bone rearrangement surgery was a success. The main question it aims to answer is: • Should the investigators perform pelvic rearrangement surgery on a patient if there's not enough bone stock to accomplish the exchange of the components? As the research started the participant was asked to attend outpatient clinics regularly and keep in touch. The investigators were able to observe the outcomes and closely explore probable risks for failure.

NCT ID: NCT06187116 Not yet recruiting - Clinical trials for Osteoarthritis, Knee

Physiotherapist Led Triage in Primary Care for Patients With Hip or Knee OA

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The overall aim with the study is to evaluate physiotherapist led triage in primary care compared to usual care (assessment by an orthopaedic surgeon in an orthopaedic department) for patients with hip or knee osteoarthritis referred for orthopaedic consultation.

NCT ID: NCT06186115 Not yet recruiting - Osteoarthritis, Hip Clinical Trials

Intraarticular Gold Microparticles for Hip Osteoarthritis

Start date: March 4, 2024
Phase:
Study type: Observational

In a pilot study, the investigators recently showed that intraarticular metallic gold microparticles reduce knee osteoarthritis pain for up to two years and found associated significant proteomic changes in serum and synovial fluid within eight weeks. This study aim to evaluate the outcome after intra-articular injection of gold microparticles for hip osteoarthritis.

NCT ID: NCT06185036 Recruiting - Osteoarthritis, Hip Clinical Trials

Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint

Start date: September 1, 2022
Phase:
Study type: Observational

In this study, the investigators seek to validate 3D model-based dGEMRIC (delayed gadolinium enhanced MRI of cartilage) values against histologic grading of cartilage quality, using osteochondral samples of the femoral head collected during hip replacement surgery.

NCT ID: NCT06173713 Not yet recruiting - Hip Osteoarthritis Clinical Trials

Emphasys Radiostereometric Analysis

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study is designed as a prospective, multi-centre, non-randomized, non-controlled study. This study does not limit the procedures involved in the treatment of the subject as long as the protocol specified products are utilized. The primary objective is to establish the mean superior cup migration of the Emphasys Shell and the mean inferior stem migration of the Emphasys Stem using model-based RSA over the first two years post-implantation. Additionally, the data from this study will be compared to historical Pinnacle Acetabular Shell data obtained in study DSJ_2018_02.

NCT ID: NCT06162195 Not yet recruiting - Osteoarthritis, Hip Clinical Trials

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

ACTIVE
Start date: September 2024
Phase: N/A
Study type: Interventional

The goal of this randomised controlled trial is to compare the success of two types of hip replacement in patients with hip arthritis. The main question it aims to answer is whether a new type of hip replacement (called a hip resurfacing) can be as successful as an existing hip replacement (called a total hip replacement). Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare their function, complication rate and physical activity.